Skip to main content

Publication, Part of

Case-mix adjusted percentage of cancers diagnosed at stages 1 and 2 in England, 2020

Publication Date:
15 Dec 2022

Current Chapter

Case-mix adjusted percentage of cancers diagnosed at stages 1 and 2 in England, 2020

View all

Next Chapter

Unadjusted and case-mix adjusted percentage of cancers diagnosed at stages 1 and 2

Correction to data tables.

In Table 5, the previous publications data was also included. This has now been removed and corrected data tables have been uploaded.

 

Please accept our apologies for any inconvenience caused.

15 December 2022 14:55 PM

Page contents

Summary

This publication presents the 1- and 3- year unadjusted and case-mix adjusted ‘percentage of all cancers diagnosed at stages 1 and 2’ indicator nationally and at sub-Integrated Care Board (ICB) level. The most recently available results are for cancers diagnosed in 2020, with data available from 2013. The unadjusted percentage of cancers diagnosed at each stage is also provided by cancer site/group and deprivation quintile. It also presents the 1-year rolling unadjusted ‘percentage of all cancers diagnosed at stages 1 and 2’ indicator (known as the ‘75% ambition’ indicator) nationally and at Cancer Alliance level, for 2013 to 2020.

Key Facts

The unadjusted percentage of cancers diagnosed at stages 1 and 2 fell in 2020

52% of cancers with a valid stage were diagnosed at stages 1 and 2 in 2020, compared to 54% in 2019

Part of the variation in the percentage of cancers diagnosed at stages 1 and 2 between sub-ICBs is associated with population characteristics

Case-mix adjusted percentages across the 106 sub-ICBs range from 50% to 58% in 2018 to 2020, which is smaller than the unadjusted range (48% to 59%) 

The unadjusted percentage of cancers diagnosed at stages 1 and 2 is lower in areas with higher deprivation

The unadjusted percentage of cancers diagnosed at stages 1 and 2 in the 20% most deprived areas of England is 7 percentage points lower than for those in the 20% least deprived areas 

The unadjusted percentage of cancers diagnosed at stages 1 and 2 varied by cancer site

This ranged from 19% (Oesophagus including cardia and gastroesophageal junction) to 91% (testis) 

Previous releases of these statistics can be found at the link below. 

Acknowledgements 

This work uses data that has been provided by patients and collected by the NHS as part of their care and support. The data are collated, maintained and quality assured by the National Disease Registration Service, which is part of NHS Digital. 

Last edited: 2 August 2023 4:40 pm